Orgenesis Inc (ORGS)
0.5121
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
0.5121
0.00 (0.00%)
After-Hours: 16:58
Orgenesis Cash from Financing (TTM): 13.62M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 13.62M |
September 30, 2023 | 31.88M |
June 30, 2023 | 39.47M |
March 31, 2023 | 45.49M |
December 31, 2022 | 39.58M |
September 30, 2022 | 19.00M |
June 30, 2022 | 9.807M |
March 31, 2022 | -2.003M |
December 31, 2021 | -0.106M |
September 30, 2021 | 0.72M |
June 30, 2021 | 0.715M |
March 31, 2021 | 1.422M |
December 31, 2020 | 5.881M |
September 30, 2020 | 16.57M |
June 30, 2020 | 16.46M |
March 31, 2020 | 23.85M |
December 31, 2019 | 24.10M |
September 30, 2019 | 18.23M |
June 30, 2019 | 37.75M |
March 31, 2019 | 38.12M |
November 30, 2018 | 35.06M |
August 31, 2018 | 34.53M |
May 31, 2018 | 17.11M |
February 28, 2018 | 8.869M |
November 30, 2017 | 8.365M |
Date | Value |
---|---|
August 31, 2017 | 6.156M |
May 31, 2017 | 5.33M |
February 28, 2017 | 6.667M |
November 30, 2016 | 2.123M |
August 31, 2016 | 5.619M |
May 31, 2016 | 5.577M |
February 29, 2016 | 5.172M |
November 30, 2015 | 6.666M |
August 31, 2015 | 1.514M |
May 31, 2015 | 2.085M |
February 28, 2015 | 2.035M |
November 30, 2014 | 2.737M |
August 31, 2014 | 2.586M |
May 31, 2014 | 0.8876M |
February 28, 2014 | 2.238M |
November 30, 2013 | 2.05M |
August 31, 2013 | 2.05M |
May 31, 2013 | 2.55M |
February 28, 2013 | 1.10M |
November 30, 2012 | 1.072M |
August 31, 2012 | 1.072M |
May 31, 2012 | 0.5717M |
February 29, 2012 | 0.4717M |
November 30, 2011 | 0.00 |
August 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.003M
Minimum
Mar 2022
45.49M
Maximum
Mar 2023
18.02M
Average
16.57M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Altimmune Inc | 86.10M |
Verastem Inc | 134.19M |
Ampio Pharmaceuticals Inc | 0.00 |
Oragenics Inc | 0.2839M |
Actinium Pharmaceuticals Inc | 14.87M |